Open research questions in Trace Elements in Health
35 unresolved questions extracted from the limitations and future-work sections of 240 Trace Elements in Health papers in our library. Each links back to the study that raised it.
What the literature leaves open
The intricate balance of copper homeostasis and its recent connection to a novel regulated cell death pathway—cuproptosis—have placed copper biology at the forefront of research in metabolic diseases and oncology. This review systematically examines this evolving field, spanning fundamental physiology to therapeutic translation. Looking forward, the insights obtained highlight several sequential and compelling directions for future investigation. Firstly, in systemic and cellular copper homeostasis, although the roles of transporters (e.g., CTR1, ATP7A/B) and chaperones (e.g., ATOX1, CCS, COX17) are well established, the regulatory mechanisms that fine-tune their activity in response to metabolic or oncogenic signals remain incompletely elucidated. Future studies should employ spatial transcriptomics and high-resolution live-cell imaging to visualize real-time copper flux and protein trafficking within specific subcellular compartments. Moreover, the newly identified role of ZnT1 in copper import underscores the potential for extensive interconnections with other metal homeostasis networks—an area ripe for exploration. Secondly, the molecular mechanism of cuproptosis has been elegantly delineated, focusing on FDX1-mediated copper reduction and its binding to lipoylated TCA cycle proteins such as DLAT. Nevertheless, key questions remain: What are the precise structural determinants underlying copper-induced protein aggregation? How is the immunogenic cell death (ICD) signature initiated via mtDNA–cGAS–STING signaling precisely regulated, and how can it be harnessed without inducing counterproductive PD-L1 upregulation? A deeper investigation into these mechanisms—using cryo-EM to characterize aggregating complexes and genetic screens to identify novel regulators of downstream signaling—will be essential. Thirdly, the critical interplay between copper homeostasis and cuproptosis underscores the cellular metabolic state as a decisive factor. The dependence on oxidative phosphorylation (OXPHOS) and the resistance conferred by glycolytic shifts (e.g., via CDKN2A) reveal a dynamic metabolic interplay. Future efforts should aim to map the “cuproptosis sensitivity landscape” across diverse cancer types and patient subtypes. This entails systematically examining how other metabolic pathways—such as branched-chain amino acid catabolism or glutaminolysis—intersect with copper toxicity. The objective is to develop predictive biomarkers, likely integrating metabolic enzyme expression, FDX1 activity, and copper transporter status, to identify patients most likely to respond. Finally, these foundational insights are already driving therapeutic innovation. Next-generation strategies should extend beyond first-generation copper ionophores (e.g., elesclomol) and complexes (e.g., DSF/Cu). Rational design of tumor-specific nanodelivery systems responsive to the tumor microenvironment (e.g., low pH, high glutathione) is crucial to enhance efficacy and minimize systemic toxicity. Furthermore, intelligent combination therapies—pairing cuproptosis inducers with OXPHOS inhibitors, glycolytic blockers, or immune checkpoint inhibitors—represent the most promising clinical avenue. Translational studies should prioritize validating these combinations in physiologically relevant models, including patient-derived organoids and humanized mouse models, to rapidly bridge the gap between the bench and the bedside. In summary, the journey from copper homeostasis to cuproptosis has introduced a new mechanistic framework for understanding cell fate and a promising therapeutic axis. By deepening molecular insights and targeting metabolic dependencies and strategically immune interactions, this field is well positioned to harness copper’s lethal potential for transformative treatments liver diseases, malignancies, and other copper-related diseases.
Nutritional assessment should be performed for all children younger than 5 years at the level of pri- mary healthcare centers and outpatient clinics. Mothers should be advised about the importance of breastfeeding as an early preventive measure against malnutrition. They should also be educated about the importance of a nutritious diet during their children’s immunization visits. Zinc and copper supplementati- on may be considered in children at risk of malnutri- tion or undernutrition, and screening of children un- der 5 years of age for zinc, copper, and other micronutrients may also be considered.
Existing research on cellular responses to IGG have revealed the broad cellular activity and potential anti-neoplastic effects of IGG, though detailed mechanistic responses to IGG and direct consequences of its splicing inhibitory activity are not fully defined.
Isoginkgetin increases the expression of metal responsive transcripts but inhibits their translation · 2026 · DOISLC transporters are re- cognized as some of the most understudied proteins consi- dering the size of their family, and numerous aspects of their biology are still not well understood (117).
The epidemic community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) lineage USA300 carries mobile genetic elements that encode copX/B and copL, conferring hyper-resistance to copper, but the role of CopL beyond extracellular copper sequestration remains unclear.
Microaerobic Copper Stress Redirects Pyruvate Metabolism and Reveals a CopL-linked Nitrogen Response in Staphylococcus aureus. · 2026 · DOIThese findings suggest that CuSO4 may have re-modulated AQP-1 and AQP-3 levels due to the tubular vacuolization and degeneration it caused; however, the effect of CuSO4 on estrogen levels in females and the vasopressin effect via AQP-2 need to be investigated in detail.
The exact mechanisms by which the brain responds to copper deficiency following disruptions to the copper transporters ATP7A and CTR1 in conditions such as Menkes disease remain unclear, though failure to supply complex IV of the respiratory chain with copper is suspected to account for substantial pathology.
Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis · 2026 · DOIConceptual gaps and interindividual variability Several important conceptual gaps remain in understanding how metal(loid)s influence immune checkpoint regulation. A major limitation is the insufficient integration of real-world exposure complexity, particularly mixed-metal(loid) exposure scenarios, which better reflect environmental and occupational conditions but remain underexplored in current studies. Another important gap is interindividual variability in susceptibility to metal(loid)s. Available evidence suggests that age and sex are associated with internal dose, also referred to as body burden, and that genetic factors are key determinants of toxic effects associated with metal(loid) exposure (51). Children may be more susceptible than adults, partly due to the incomplete development of biotransformation and excretory pathways (52). In addition, sexspecific associations between metal(loid) exposure and immunerelated outcomes have been reported, with effect estimates differing between females and males (53). Genetic variants, such as singlenucleotide polymorphisms, may contribute to interindividual differences in toxicokinetics, including absorption, distribution, metabolism, excretion, internal dose, and antioxidant defense capacity (51). These differences may also reflect variation in exposure sources, lifestyle factors such as diet and tobacco smoking, and sociodemographic characteristics, as well as age-related differences in biotransformation and excretory capacity (54). However, these modifying factors have not been systematically evaluated in the context of immune checkpoint modulation or combined metal(loid) exposures. A major limitation of the current literature is the overwhelming predominance of studies focused on the PD-1/PD-L1 axis, whereas the potential effects of metal(loid)s on other immune checkpoints, including CTLA-4, TIM-3, LAG-3, and TIGIT, remain largely unexplored. Future research should therefore move beyond the current PD-1/PD-L1-centric paradigm and systematically investigate whether metal(loid)s exert broader immunomodulatory effects across multiple immune checkpoint pathways. 9.2 Context-dependent effects and unresolved mechanistic questions Current evidence suggests that the immunological effects of metal(loid)s are highly context dependent, yet the determinants of these differential effects remain incompletely understood. For example, clinical observational studies have reported that elevated serum zinc levels after 3 weeks of ICI treatment are significantly associated with improved overall survival in patients with advanced cancer, suggesting its potential role as a noninvasive prognostic biomarker (55). In contrast, mechanistic studies have shown that high zinc levels can promote the expansion of FOXP3+ Tregs, upregulate PD-1 expression on T cells, suppress Th1-type antitumor immune responses, and potentially reduce the efficacy of anti- PD-1 therapies (24). These findings are not inherently contradictory but reflect differences in dose dependency, spatial distribution, timing of measurement, and baseline patient characteristics. Specifically, increases in serum zinc associated with improved outcomes may reflect restoration of physiological homeostasis following correction of deficiency, whereas immunosuppressive effects are more often linked to supraphysiological supplementation or abnormal accumulation within the tumor microenvironment (24, 55). Similarly, arsenic compounds exhibit bidirectional effects on PD-L1 regulation that depend on chemical form, exposure dose, cellular genotype, and molecular pathway specificity. Arsenic sul- fide can suppress PD-L1 expression through activation of the p53/ miR-34a-5p axis in p53-wild-type tumors, whereas arsenic trioxide can induce PD-L1 upregulation through ROS-mediated DNA damage and inhibition of ubiquitin-dependent degradation pathways (13, 14). Iron also demonstrates dual effects, with local iron overload promoting tumor immune evasion through ROS-mediated signaling, while physiological supplementation may enhance T-cellmediated antitumor responses and improve immunotherapy effi- cacy (18–20). These context-dependent effects are driven by multiple factors, including dose thresholds, spatial distribution between systemic circulation and the TIME, chemical speciation, and cell typespecific signaling pathways. Despite these insights, key questions remain unresolved, including dose-response relationships within clinically relevant exposure ranges, spatial heterogeneity, and the net effects of mixedmetal(loid) exposure. Metal(loid)-related health risks might be amplified by mixed exposures, which are hypothesized to produce synergistic toxicity that could surpass individual effects.
Modulation of the PD-1/PD-L1 axis and tumor immunity by metals and metalloids: mechanistic insights and human health implications · 2026 · DOIWD patients exhibit strong clinical phenotype heterogeneity, such as varying degrees of liver fibrosis and differing durations of copper chelation therapy, resulting in data characterized by small sample size, high dimensionality, and nonlinearity.
Development and validation of a machine learning model for predicting hypersplenism in Wilson disease patients · 2026 · DOIUndoubtedly, cellular zinc metabolism and zinc signaling are critical in a variety of biological functions, spanning from essential cellular processes to the development and progression of various diseases. Zinc acts as an essential modulator of cell homeostasis as well as is engaged in key signaling pathways that impact cell immune responses, and DNA repair. growth, proliferation, Dysregulation of zinc metabolism and signaling has been linked to numerous diseases, including cancer, neurodegenerative disorders, and infectious diseases. Evidence suggests that a safe range of zinc intake is negatively risk. However, cancer cells inevitably associated with cancer require more zinc to maintain the oncogenic properties and metastasis, which functionally relies on the zinc transporter. Previous studies reported that the zinc transporter is aberrantly elevated and activated among multiple tumor types, particularly GI cancers. The significant upregulation of zinc transporters in GI cancers might be because that zinc absorption depends on the epithelial cells of the GI tract, which is the most vulnerable region for zinc homeostasis disorders. In BC and ESCC, zinc transporter ZIP6 is regarded as a diagnostic and prognostic biomarker.
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets · 2024 · DOIFurther investigations showed no signs of paraneoplastic syndrome in this case, but systematic screening protocols for paraneoplastic involvement in ENPP1-related hypophosphatemia need to be established.
The relationship between the ENPP1 p.D85H mutation and the accompanying hearing loss phenotype requires further mechanistic investigation to understand if this is a consistent feature of this specific mutation.
The paper presents a single case report of a Turkish male patient; broader investigation across different populations and family members is needed to establish the prevalence and phenotypic variability of the ENPP1 p.D85H mutation.
Early onset conductive hearing loss may further distinguish ENPP1-related hypophosphatemia from other types of hypophosphatemia, but this distinction requires further systematic investigation across patient populations.
Many questions remain to be deciphered with respect to Cu’s role in biology, including an articulation of the entire constellation of Cu-dependent processes, how hosts and microbes interact with respect to Cu, how cells and organs distribute and communicate their Cu status, and precisely how Cu dysregulation contributes to human disease.
In Bacillus subtilis , the YcnJ membrane protein has been proposed to serve as a copper importer, but its biological function remains poorly characterized.
Pathways of copper import and utilization that support respiration in <i>Bacillus subtilis</i> · 2026 · DOITrace element imbalances are implicated in cancer pathophysiology, yet data from Iraq, a country with distinct environmental and industrial exposures, remain scarce.
Serum Zinc, Copper, and Lead Levels in Iraqi Gastric Cancer Patients: A Gender-Stratified Case-Control Study with ROC Diagnostic Analysis · 2026 · DOIHowever, a major limitation of fluopsin C has historically been its nonspecific cytotoxicity toward eukaryotic cells, which precludes routine systemic use.
Copper homeostasis networks in pseudomonas aeruginosa and the organocopper metabolite fluopsin C · 2026 · DOIIncorporating dynamic and genetic factors such as treatment regimens, lifestyle habits, and genetic polymorphisms could optimize feature sets and enhance predictive accuracy.
Development and validation of a machine learning model for predicting hypersplenism in Wilson disease patients · 2026 · DOITo better adapt to primary care settings, further research will explore a simplified scoring model based on categorical variables and expand the sample size for multicenter validation to facilitate clinical translation.
Development and validation of a machine learning model for predicting hypersplenism in Wilson disease patients · 2026 · DOINormal plasma concentrations in earlier studies varied widely, probably because of unrecognized con- tamination with zinc in the process of collec- tion and analysis of samples and because of difficulties in the analytical techniques.
Most-cited papers in Trace Elements in Health
- Copper induces cell death by targeting lipoylated TCA cycle proteins · Science · 2022 · 4,177 citations
- Copper: An essential metal in biology · Current Biology · 2011 · 1,083 citations
- Copper biology · Current Biology · 2021 · 366 citations
- Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets · Signal Transduction and Targeted Therapy · 2024 · 330 citations
- Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update · International Journal of Molecular Sciences · 2024 · 106 citations
- Zinc transporter 1 functions in copper uptake and cuproptosis · Cell Metabolism · 2024 · 102 citations
- PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis · Nature Structural & Molecular Biology · 2024 · 98 citations
- Copper homeostasis and neurodegenerative diseases · Neural Regeneration Research · 2024 · 81 citations
- Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species · Acta Biomaterialia · 2024 · 80 citations
- Serum copper and zinc levels and the risk of oral cancer: A new insight based on large‐scale case–control study · Oral Diseases · 2018 · 69 citations
Most recent work
- Effects of essential metals (iron, zinc, and copper) on thyroid diseases - a narrative review · Frontiers in Medicine · 2026
- Copper deficiency impairs oligodendrocyte maturation and social behavior via mitophagy and mTOR suppression in ASD · Science Advances · 2026
- Zinc-redox crosstalk regulates proteostasis in the endoplasmic reticulum · Nature Communications · 2026
- Intracellular copper redox modulation disrupts ROS–Ca²⁺ amplification in an ATP7B-deficient zebrafish model of Wilson’s disease · Advances in Redox Research · 2026
- Development and validation of a machine learning model for predicting hypersplenism in Wilson disease patients · Frontiers in Medicine · 2026
- Commentary: The Lack of Biomarkers to Assess Copper Status Could be Dangerous to Your Health? · Biological Trace Element Research · 2026
- The Role of Metal Ions in Mitochondria: From Energy Metabolism to Cell Destiny · Biological Trace Element Research · 2026
- A case of copper-dependent hepatosis in a dog · Legal regulation in veterinary medicine · 2026
- FDA approval of copper histidinate (Zycubo) for Menkes disease: a therapeutic breakthrough in a rare pediatric neurodegenerative disorder · Annals of Medicine & Surgery · 2026
- Copper homeostasis networks in pseudomonas aeruginosa and the organocopper metabolite fluopsin C · International Microbiology · 2026
Find a gap in your own Trace Elements in Health sub-topic
This page shows what the Trace Elements in Health literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →